Our research demonstrated that the fusion of GBM cells and GA-MSCs leads to FTO-mediated changes in CSF1 mRNA m6A modification, consequently remodeling the macrophage-related TME through CSF1. The gene discussed is CSF1; the disease is glioblastoma.